Boehringer Ingelheim initiates phase I study of BI-1701963 alone or in combination with BI-3011441 April 30, 2021
New phase II study in China evaluates HMPL-689 in follicular lymphoma and marginal zone lymphoma April 29, 2021
Galera reports updated phase I/II study data on GC-4419 in locally advanced pancreatic cancer April 29, 2021
ESSA and Bayer enter clinical collaboration to evaluate EPI-7386 plus darolutamide in mCRPC April 29, 2021
Agios Pharmaceuticals and the University of Michigan describe menin/MLL interaction inhibitors April 29, 2021
RSS